Articles

The document gives guidance on the limited population pathway for antibacterial and antifungal drugs.

FDA Publishes Guidance on Antibacterial and Antifungal Drugs

PPD announced it will provide drug development services to advance Pfizer’s portfolio.

PPD and Pfizer Enter into Three-Year Agreement

Jill Wechsler is Pharmaceutical Technology's Washington Editor, jillwechsler7@gmail.com.

As biopharma companies and research institutes work to develop vaccines against COVID-19, policy makers and health officials debate strategies for ensuring fair and equitable distribution of anticipated preventives. 

Debate Accelerates Over Who Gets COVID Vaccine First

The investment will allow for the expansion of analytical R&D efforts and will support the company’s reference materials business.

MilliporeSigma Invests $20 Million in New Switzerland Laboratory

The company’s SLIM technology has been a part of the company’s accelerated growth by offering enhanced R&D analytics.

MOBILIon’s SLIM Technology Enhances R&D Analytics

The company has launched a residual GMP-compliant test and dual sourcing opportunity designed to increase compliance and reduce risks for ATMP manufacture.

Polyplus-transfection Launches Residual Test for Transfection Reagents 

Tony Cordrey is vice‑president of European Strategic Operations, Accord Healthcare.

COVID-19 has brought to light the issues of European manufacturing capabilities, leading industry to question whether it is now time to reinvest in domestic medicines supply.

Reinvesting in European Manufacturing

Efforts by regulators seek common approaches to clinical research and biopharmaceutical production needed to wipe out the coronavirus pandemic globally. 

Global Regulatory Collaborations Aim to Speed Access to New Vaccines and Drugs

Sean Milmo is a freelance writer based in Essex, UK.

EU regulators are requesting more effective action be taken to tackle serious impurities in APIs and finished products.

Tackling Serious Impurities

Felicity Thomas is Associate Editorial Director of Pharmaceutical Technology, Pharmaceutical Technology Europe, BioPharm International.

COVID-19’s impact on the global economy is dealing a blow to merger and acquisition activity in the biopharma industry.

News